PL3583103T3 - Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznych - Google Patents
Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznychInfo
- Publication number
- PL3583103T3 PL3583103T3 PL18707229.3T PL18707229T PL3583103T3 PL 3583103 T3 PL3583103 T3 PL 3583103T3 PL 18707229 T PL18707229 T PL 18707229T PL 3583103 T3 PL3583103 T3 PL 3583103T3
- Authority
- PL
- Poland
- Prior art keywords
- ipoliamide
- immunosupressants
- derivatives
- treatment
- plant extracts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/92—Unsaturated compounds containing keto groups containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102017003318-0A BR102017003318A2 (pt) | 2017-02-17 | 2017-02-17 | compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas |
| PCT/BR2018/050037 WO2018148816A2 (en) | 2017-02-17 | 2018-02-19 | Compounds, process of production of compounds, enriched extract, enriched extract active fractions, enriched extract process of production, method for selecting vegetal biomass for enriched extract production, composition and use for treatment of immunological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3583103T3 true PL3583103T3 (pl) | 2022-08-01 |
Family
ID=61282932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18707229.3T PL3583103T3 (pl) | 2017-02-17 | 2018-02-19 | Wyciągi roślinne wzbogacone w pochodne ipoliamidu jako immunosupresanty do leczenia zaburzeń immunologicznych |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US12698265B2 (pl) |
| EP (2) | EP3583103B1 (pl) |
| JP (2) | JP7349362B2 (pl) |
| KR (2) | KR102882868B1 (pl) |
| CN (1) | CN110475768B (pl) |
| AU (2) | AU2018221956B2 (pl) |
| BR (1) | BR102017003318A2 (pl) |
| CA (2) | CA3052713A1 (pl) |
| CL (1) | CL2019002309A1 (pl) |
| CO (1) | CO2019008891A2 (pl) |
| CY (1) | CY1125187T1 (pl) |
| DK (1) | DK3583103T3 (pl) |
| EC (1) | ECSP19058322A (pl) |
| ES (1) | ES2909387T3 (pl) |
| HR (1) | HRP20220377T1 (pl) |
| IL (2) | IL268732B2 (pl) |
| LT (1) | LT3583103T (pl) |
| MX (2) | MX2019009655A (pl) |
| PE (2) | PE20242300A1 (pl) |
| PL (1) | PL3583103T3 (pl) |
| PT (1) | PT3583103T (pl) |
| RS (1) | RS63162B1 (pl) |
| SA (1) | SA519402443B1 (pl) |
| SG (1) | SG11201907375VA (pl) |
| SI (1) | SI3583103T1 (pl) |
| SM (1) | SMT202200121T1 (pl) |
| WO (1) | WO2018148816A2 (pl) |
| ZA (2) | ZA201906106B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR102017003318A2 (pt) | 2017-02-17 | 2018-10-30 | Aché Laboratórios Farmacêuticos S.A. | compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas |
| CN115304652A (zh) * | 2022-07-25 | 2022-11-08 | 福建华闽晟业生物科技有限公司 | 一种利用巨菌草制备野芝麻新甙的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3703543A (en) * | 1969-11-05 | 1972-11-21 | American Home Prod | Hydroxamic acids of alicyclic amino acids |
| IL57433A (en) * | 1978-06-03 | 1982-08-31 | Inst Rech Chim Biolog | Pharmaceutical compositions containing cyclopentane derivatives |
| DE3030477C2 (de) * | 1980-08-12 | 1986-10-16 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Iridoid-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung |
| JPH0366682A (ja) * | 1989-08-04 | 1991-03-22 | Tsumura & Co | 新規イリドイド誘導体 |
| AU651849B2 (en) * | 1990-10-09 | 1994-08-04 | Tsumura & Co. | Iridoid derivatives and their use as medicines |
| DE19644422C2 (de) | 1996-10-25 | 2000-06-15 | Stefan Schulz | Verwendung von Terpenen zur Behandlung von Autoimmunkrankheiten und bei Transplantat-Abstoßungsreaktionen |
| EP1145709A1 (de) * | 2000-04-14 | 2001-10-17 | Laboratoires Serobiologiques | Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen |
| DE60336549D1 (de) * | 2002-05-10 | 2011-05-12 | Council Scient Ind Res | Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure |
| EP1371372A1 (de) * | 2002-06-08 | 2003-12-17 | Cognis Iberia, S.L. | Verwendung von Wirkstoffgemischen enthaltend Tocopherole und Extrakte des Harpagophytum procumbens zur Herstellung eines Medikamentes gegen rheumatische Arthritis |
| US7501222B2 (en) * | 2005-06-24 | 2009-03-10 | Dongjin Semichem Co., Ltd. | Photoresist monomer polymer thereof and photoresist composition including the same |
| JP2008024670A (ja) * | 2006-07-24 | 2008-02-07 | Daiwa Kagaku Kogyo Kk | 害虫駆除剤 |
| US8552210B2 (en) * | 2006-12-21 | 2013-10-08 | E I Du Pont De Nemours And Company | Hydrogenation of catmint oil |
| BRPI0700767B8 (pt) | 2007-02-15 | 2021-05-25 | Ache Laboratorios Farmaceuticos Sa | composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo |
| KR101406933B1 (ko) * | 2011-09-02 | 2014-06-12 | 동국대학교 산학협력단 | 라카아제를 이용한 새로운 효소형 시간-온도 이력지시계 |
| CN103120699B (zh) * | 2011-11-18 | 2017-04-19 | 天津市国际生物医药联合研究院 | 环烯醚萜类化合物在制备抗sars的药物中的应用 |
| CN103690551A (zh) * | 2013-07-18 | 2014-04-02 | 江苏大学 | 猪殃殃中环烯醚萜苷提取物及其提取方法和医药用途 |
| DE102015102020A1 (de) * | 2015-02-12 | 2016-08-18 | Renate Wilmanowicz | Immunologisch aktives Phyto-Gemisch und seine Anwendung bei der Prävention und in einem Verfahren zur Behandlung von Effloreszenzen |
| BR102017003318A2 (pt) | 2017-02-17 | 2018-10-30 | Aché Laboratórios Farmacêuticos S.A. | compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas |
-
2017
- 2017-02-17 BR BR102017003318-0A patent/BR102017003318A2/pt active Search and Examination
-
2018
- 2018-02-19 DK DK18707229.3T patent/DK3583103T3/da active
- 2018-02-19 PE PE2024002048A patent/PE20242300A1/es unknown
- 2018-02-19 SM SM20220121T patent/SMT202200121T1/it unknown
- 2018-02-19 PT PT187072293T patent/PT3583103T/pt unknown
- 2018-02-19 EP EP18707229.3A patent/EP3583103B1/en active Active
- 2018-02-19 ES ES18707229T patent/ES2909387T3/es active Active
- 2018-02-19 JP JP2019544005A patent/JP7349362B2/ja active Active
- 2018-02-19 KR KR1020197026718A patent/KR102882868B1/ko active Active
- 2018-02-19 RS RS20220241A patent/RS63162B1/sr unknown
- 2018-02-19 IL IL268732A patent/IL268732B2/en unknown
- 2018-02-19 PE PE2019001711A patent/PE20200449A1/es unknown
- 2018-02-19 MX MX2019009655A patent/MX2019009655A/es unknown
- 2018-02-19 CA CA3052713A patent/CA3052713A1/en active Pending
- 2018-02-19 WO PCT/BR2018/050037 patent/WO2018148816A2/en not_active Ceased
- 2018-02-19 HR HRP20220377TT patent/HRP20220377T1/hr unknown
- 2018-02-19 CA CA3259255A patent/CA3259255A1/en active Pending
- 2018-02-19 KR KR1020257031344A patent/KR20250145126A/ko active Pending
- 2018-02-19 SG SG11201907375VA patent/SG11201907375VA/en unknown
- 2018-02-19 LT LTEPPCT/BR2018/050037T patent/LT3583103T/lt unknown
- 2018-02-19 CN CN201880018995.0A patent/CN110475768B/zh active Active
- 2018-02-19 US US16/486,683 patent/US12698265B2/en active Active
- 2018-02-19 EP EP21215133.6A patent/EP4001270A1/en active Pending
- 2018-02-19 SI SI201830594T patent/SI3583103T1/sl unknown
- 2018-02-19 PL PL18707229.3T patent/PL3583103T3/pl unknown
- 2018-02-19 IL IL313974A patent/IL313974A/en unknown
- 2018-02-19 AU AU2018221956A patent/AU2018221956B2/en active Active
-
2019
- 2019-08-13 MX MX2022012282A patent/MX2022012282A/es unknown
- 2019-08-14 CL CL2019002309A patent/CL2019002309A1/es unknown
- 2019-08-14 EC ECSENADI201958322A patent/ECSP19058322A/es unknown
- 2019-08-15 SA SA519402443A patent/SA519402443B1/ar unknown
- 2019-08-15 CO CONC2019/0008891A patent/CO2019008891A2/es unknown
- 2019-09-16 ZA ZA2019/06106A patent/ZA201906106B/en unknown
-
2022
- 2022-03-16 AU AU2022201835A patent/AU2022201835B2/en active Active
- 2022-03-21 CY CY20221100223T patent/CY1125187T1/el unknown
-
2023
- 2023-01-25 JP JP2023009384A patent/JP7685540B2/ja active Active
-
2025
- 2025-02-28 ZA ZA2025/01840A patent/ZA202501840B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL293783A (en) | Compounds and compositions for treating hematological disorders | |
| IL279752A (en) | Polycyclic compounds and use thereof in the treatment of immune disorders | |
| IL280710A (en) | Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy | |
| IL285151A (en) | Methods of treating fgf21-associated disorders | |
| IL271085A (en) | Bacteria for the treatment of disorders | |
| IL263484A (en) | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders | |
| HUE064141T2 (hu) | Azolopirimidin rákkal összefüggõ rendellenességek kezelésére | |
| EA201691582A1 (ru) | Новые фармацевтические препараты | |
| IL246833A0 (en) | New salts and their pharmaceutical preparations for the treatment of inflammatory disorders | |
| LT3224269T (lt) | Kompozicijos ir būdai, skirti cns sutrikimams gydyti | |
| HUE059041T2 (hu) | Eljárás KIT-tel összefüggõ rendellenességek kezelésére alkalmas kompozíciók elõállítására | |
| LT3250210T (lt) | Kompozicijos ir būdai, skirti gydyti cns sutrikimus | |
| DK3936130T3 (da) | Doseringsskema for Valbenazin til behandling af hyperkinetiske bevægelsesforstyrrelser | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| IL259861A (en) | Methods and compositions for the treatment of seizure-related disorders | |
| IL262852A (en) | Treatment of complement-mediated disorders | |
| IL262348A (en) | Preparations for the treatment of excessive radiation disorders | |
| HUE043206T2 (hu) | Kortisztatin-analógok gyulladásos és/vagy immunbetegségek kezelésére | |
| PL3348273T3 (pl) | Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych | |
| PL3452012T3 (pl) | Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych | |
| IL280227A (en) | Arimoclomol for treating glucocerebrosidase associated disorders | |
| HUE062857T2 (hu) | Készítmény hajnövekedési rendellenességek megelõzésére és kezelésére | |
| IL262479A (en) | Methods and formulations for treatment and/or prevention of blood-associated disorders | |
| IL268732A (en) | Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders | |
| BR112016019893A2 (pt) | composições de glicoproteína sialilada e seus usos |